Bioelectronics Corp (BIEL)

[luke5516]

Thanks, this is not at all surprising and doesn’t give me any cause for concern. In a perfect world, they wouldn’t need the AS increase from all the money rolling in.

However, I have been expecting this (as I’m sure others have) and am surprised that they went this long without an increase. An educated guess is that they need this to ramp up production (their orders to their manufacturers in China [if memory serves, that’s where they are]) along with their other ongoing costs (510k application, legal costs related to the SEC matter, redesign of packaging including KT tape, etc.)

Looks like full clearance and Dr. Scholl’s/Bayer may happen by the end of the summer and then the 5 bln increase will be only a blip on the trajectory of BIEL’s SP.

As filings go, this is much better than a RS, and the increase is relatively modest. AW has said NHS should increase UK sales by multiples, so that may make this AS increase the last one. Assuming they don’t have a Tesla issue of their costs outpacing their profits, NHS sales allow them to meet their ongoing expenses and they turn profitable by a few dollars.